Companies Cryptocurrencies
Stoke Therapeutics Inc
Stoke Therapeutics Inc
Exchange: NasdaqGS
IPO Date: 19/06/2019
CEO: Dr. Edward Kaye
Biotechnology Healthcare 🔗
  • STOK
  • 15.82
  • 619981056
    market cap
  • -0.07999992
If you bought

shares of Stoke Therapeutics Inc (STOK) on
You would have made
Old Price $12 Current Price $12

Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. The company is headquartered in Bedford, Massachusetts and currently employs 44 full-time employees. The firm develops antisense oligonucleotide medicines that target ribo-nucleic acid (RNA) splicing to increase gene expression for the treatment of severe genetic diseases. The company uses targeted augmentation of nuclear gene output (TANGO) to effect targeted enhancement of gene expression. The company provides TANGO, which is a precision medicine platform for treating a category of genetic diseases, such as autosomal dominant haploinsufficiency. TANGO is designed to address protein deficiency by upregulating target protein expression.

Address: 3 Preston Ct Bedford MASSACHUSETTS 01730

Stay updated.